Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
J Immunol. 2014 May 15;192(10):4887-96. doi: 10.4049/jimmunol.1303481. Epub 2014 Apr 11.
Activation-induced cytidine deaminase (AID) initiates Ab class-switch recombination (CSR) in activated B cells resulting in exchanging the IgH C region and improved Ab effector function. During CSR, AID instigates DNA double-strand break (DSB) formation in switch (S) regions located upstream of C region genes. DSBs are necessary for CSR, but improper regulation of DSBs can lead to chromosomal translocations that can result in B cell lymphoma. The protein kinase ataxia telangiectasia mutated (ATM) is an important proximal regulator of the DNA damage response (DDR), and translocations involving S regions are increased in its absence. ATM phosphorylates H2AX, which recruits other DNA damage response (DDR) proteins, including mediator of DNA damage checkpoint 1 (Mdc1) and p53 binding protein 1 (53BP1), to sites of DNA damage. As these DDR proteins all function to promote repair and recombination of DSBs during CSR, we examined whether mouse splenic B cells deficient in these proteins would show alterations in S region DSBs when undergoing CSR. We find that in atm(-/-) cells Sμ DSBs are increased, whereas DSBs in downstream Sγ regions are decreased. We also find that mutations in the unrearranged Sγ3 segment are reduced in atm(-/-) cells. Our data suggest that ATM increases AID targeting and activity at downstream acceptor S regions during CSR and that in atm(-/-) cells Sμ DSBs accumulate as they lack a recombination partner.
激活诱导胞嘧啶脱氨酶(AID)在激活的 B 细胞中启动抗体类别转换重组(CSR),导致 IgH C 区的交换和抗体效应功能的改善。在 CSR 过程中,AID 在位于 C 区基因上游的开关(S)区域引发 DNA 双链断裂(DSB)的形成。DSB 是 CSR 所必需的,但 DSB 的不当调节会导致染色体易位,从而导致 B 细胞淋巴瘤。共济失调毛细血管扩张突变蛋白激酶(ATM)是 DNA 损伤反应(DDR)的重要近端调节剂,并且在其缺失的情况下,涉及 S 区的易位增加。ATM 磷酸化 H2AX,募集其他 DNA 损伤反应(DDR)蛋白,包括 DNA 损伤检查点 1 (Mdc1)和 p53 结合蛋白 1 (53BP1),到 DNA 损伤部位。由于这些 DDR 蛋白都在 CSR 过程中促进 DSB 的修复和重组,我们检查了在经历 CSR 时缺乏这些蛋白的小鼠脾脏 B 细胞中 S 区 DSB 是否会发生变化。我们发现,在 atm(-/-)细胞中,Sμ DSB 增加,而下游 Sγ 区域的 DSB 减少。我们还发现,在 atm(-/-)细胞中,未重排的 Sγ3 片段的突变减少。我们的数据表明,ATM 在 CSR 期间增加了下游受体 S 区的 AID 靶向和活性,并且在 atm(-/-)细胞中,由于缺乏重组伙伴,Sμ DSB 会积累。